Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies

BACKGROUND: T-cell malignancies (TCMs), including T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoma (TCL), are highly aggressive and have a poor prognosis. To further understand prognostic stratifications and to design targeted therapies, this study aims to explore novel, potential bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Songnan, Li, Zhiyan, Tan, Jiaxiong, Wang, Liang, Luo, Gengxin, Zeng, Chengwu, Luo, Oscar Junhong, Chen, Cunte, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381250/
https://www.ncbi.nlm.nih.gov/pubmed/35983088
http://dx.doi.org/10.1155/2022/2787426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381250/
https://www.ncbi.nlm.nih.gov/pubmed/35983088
http://dx.doi.org/10.1155/2022/2787426

Ejemplares similares